Sunday, February 03, 2013

Treatment to Prevent Alzheimer's Disease Moves a Step Closer

Some Republican lawmakers are trying to make the creation of such mice illegal.

http://www.sciencedaily.com/releases/2013/02/130201100147.htm

Feb. 1, 2013 — A new drug to prevent the early stages of Alzheimer's disease could enter clinical trials in a few years' time according to scientists.

-----

Professor David Allsop and Dr Mark Taylor at Lancaster University have successfully created a new drug which can reduce the number of senile plaques by a third, as well as more than doubling the number of new nerve cells in a particular region of the brain associated with memory. It also markedly reduced the amount of brain inflammation and oxidative damage associated with the disease.

The drug was tested on transgenic mice containing two mutant human genes linked to inherited forms of Alzheimer's, so that they would develop some of the changes associated with the illness. The drug is designed to cross the blood-brain barrier and prevent the Aβ molecules from sticking together to form plaques.

Professor Allsop, who led the research and was the first scientist to isolate senile plaques from human brain, said: "When we got the test results back, we were highly encouraged. The amount of plaque in the brain had been reduced by a third and this could be improved if we gave a larger dose of the drug, because at this stage, we don't know what the optimal dose is."

-----

No comments:

Post a Comment